Karin Nord
Founder at Affibody Medical AB
Karin Nord active positions
Companies | Position | Start | End |
---|---|---|---|
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Chief Operating Officer | - | - |
Founder | 01/01/1998 | - |
Career history of Karin Nord
Former positions of Karin Nord
Companies | Position | Start | End |
---|---|---|---|
Affibody AB
Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Chief Operating Officer | 02/11/2009 | - |
Chief Tech/Sci/R&D Officer | 01/01/2000 | 02/11/2009 | |
Founder | 24/01/2011 | - |
Training of Karin Nord
Royal Institute of Technology | Doctorate Degree |
Statistics
International
Sweden | 4 |
Operational
Chief Operating Officer | 2 |
Founder | 2 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 2 |
Commercial Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Affibody AB
Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Commercial Services |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
- Stock Market
- Insiders
- Karin Nord
- Experience